|
Volumn 20, Issue 3, 2008, Pages 309-310
|
Commentary on "A review of the trials comparing carotid endarterectomy and carotid angioplasty and stenting"
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ARTERY CATHETERIZATION;
BRAIN BLOOD FLOW;
BRAIN EMBOLISM;
BRAIN PROTECTION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CAROTID ARTERY OBSTRUCTION;
CAROTID ENDARTERECTOMY;
CEREBRAL REVASCULARIZATION;
CEREBROVASCULAR ACCIDENT;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL;
EQUIPMENT DESIGN;
HIGH RISK PATIENT;
HUMAN;
MEDICAL EDUCATION;
MONOTHERAPY;
NOTE;
PATIENT SAFETY;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PERSONAL EXPERIENCE;
PRIORITY JOURNAL;
RISK REDUCTION;
STENT;
SYMPTOM;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ANGIOPLASTY;
CAROTID STENOSIS;
ENDARTERECTOMY, CAROTID;
HUMANS;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REGISTRIES;
RESEARCH DESIGN;
RISK ASSESSMENT;
STENTS;
TREATMENT OUTCOME;
|
EID: 54249107938
PISSN: 15310035
EISSN: 15310027
Source Type: Journal
DOI: 10.1177/1531003508325409 Document Type: Note |
Times cited : (2)
|
References (7)
|